Limits...
2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase.

Kuang S, Qi C, Liu J, Sun X, Zhang Q, Sima Z, Liu J, Li W, Yu Q - Cancer Sci. (2014)

Bottom Line: We have identified 2-methoxystypandrone (2-MS) from a traditional Chinese medicinal herb Polygonum cuspidatum as a novel dual inhibitor of JAK2 and IKK. 2-MS inhibits both interleukin-6-induced and constitutively-activated STAT3, as well as tumor necrosis factor-α-induced NF-κB activation. 2-MS specifically inhibits JAK and IKKβ kinase activities but has little effect on activities of other kinases tested.The inhibitory effects of 2-MS on STAT3 and NF-κB signaling can be eliminated by DTT or glutathione and can last for 4 h after a pulse treatment.We propose that the natural compound 2-MS, as a potent dual inhibitor of STAT3 and NF-κB pathways, is a promising anticancer drug candidate.

View Article: PubMed Central - PubMed

Affiliation: Division of Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Show MeSH

Related in: MedlinePlus

2-Methoxystypandrone (2-MS) inhibited growth of human cancer cells. (a) Real-time cell analysis (RTCA) system analysis of 2-MS's effects on HeLa cells. (b) IC50 of 2-MS on viability of different human tumor cell lines for 72 h. (c) HeLa cells were pretreated with indicated concentrations of 2-MS for 24 h. Cells were then stained with Annexin V-Alexa Fluor 488 Apoptosis Detection Kit before analysis of apoptosis through flow cytometry. (d) Lysates from four human prostate and lung cancer cell lines DU-145, PC-3, A549 and H460 were processed for western blot analysis using specific antibodies as indicated. (e) DU-145, PC-3, A549 and H460 cells were treated with 2-MS at various concentrations for 72 h and then processed for MTT assay.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4317813&req=5

fig07: 2-Methoxystypandrone (2-MS) inhibited growth of human cancer cells. (a) Real-time cell analysis (RTCA) system analysis of 2-MS's effects on HeLa cells. (b) IC50 of 2-MS on viability of different human tumor cell lines for 72 h. (c) HeLa cells were pretreated with indicated concentrations of 2-MS for 24 h. Cells were then stained with Annexin V-Alexa Fluor 488 Apoptosis Detection Kit before analysis of apoptosis through flow cytometry. (d) Lysates from four human prostate and lung cancer cell lines DU-145, PC-3, A549 and H460 were processed for western blot analysis using specific antibodies as indicated. (e) DU-145, PC-3, A549 and H460 cells were treated with 2-MS at various concentrations for 72 h and then processed for MTT assay.

Mentions: The STAT3 and NF-κB signaling pathways play an important role in tumor cell survival and growth. Therefore, we analyzed the effects of 2-MS on the growth and survival of a panel of human tumor cell lines. We first examined the 2-MS's effects on HeLa cells using a real-time cell analysis system. As shown in Figure. 7(a), 2-MS exhibited inhibitory effects on HeLa cells and 10 μM 2-MS totally inhibited the cell growth. 2-MS inhibited the growth of all human tumor cell lines we examined with an IC50 between 2.5 to 12.5 μM (Figure. 7b). Many STAT3 and NF-κB pathway inhibitors inhibit cell growth by inducing apoptosis.(9–14,24,25) Therefore, we tested the ability of 2-MS to induce apoptosis. As shown in Figure. 7(c), 2-MS mostly induced necrosis of the tumor cells, as indicated by the single PI staining. We also examined the effects of 2-MS on the PARP cleavage in the tumor cells. However, we did not detect the PARP cleavage caused by 2-MS (data not shown).


2-Methoxystypandrone inhibits signal transducer and activator of transcription 3 and nuclear factor-κB signaling by inhibiting Janus kinase 2 and IκB kinase.

Kuang S, Qi C, Liu J, Sun X, Zhang Q, Sima Z, Liu J, Li W, Yu Q - Cancer Sci. (2014)

2-Methoxystypandrone (2-MS) inhibited growth of human cancer cells. (a) Real-time cell analysis (RTCA) system analysis of 2-MS's effects on HeLa cells. (b) IC50 of 2-MS on viability of different human tumor cell lines for 72 h. (c) HeLa cells were pretreated with indicated concentrations of 2-MS for 24 h. Cells were then stained with Annexin V-Alexa Fluor 488 Apoptosis Detection Kit before analysis of apoptosis through flow cytometry. (d) Lysates from four human prostate and lung cancer cell lines DU-145, PC-3, A549 and H460 were processed for western blot analysis using specific antibodies as indicated. (e) DU-145, PC-3, A549 and H460 cells were treated with 2-MS at various concentrations for 72 h and then processed for MTT assay.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4317813&req=5

fig07: 2-Methoxystypandrone (2-MS) inhibited growth of human cancer cells. (a) Real-time cell analysis (RTCA) system analysis of 2-MS's effects on HeLa cells. (b) IC50 of 2-MS on viability of different human tumor cell lines for 72 h. (c) HeLa cells were pretreated with indicated concentrations of 2-MS for 24 h. Cells were then stained with Annexin V-Alexa Fluor 488 Apoptosis Detection Kit before analysis of apoptosis through flow cytometry. (d) Lysates from four human prostate and lung cancer cell lines DU-145, PC-3, A549 and H460 were processed for western blot analysis using specific antibodies as indicated. (e) DU-145, PC-3, A549 and H460 cells were treated with 2-MS at various concentrations for 72 h and then processed for MTT assay.
Mentions: The STAT3 and NF-κB signaling pathways play an important role in tumor cell survival and growth. Therefore, we analyzed the effects of 2-MS on the growth and survival of a panel of human tumor cell lines. We first examined the 2-MS's effects on HeLa cells using a real-time cell analysis system. As shown in Figure. 7(a), 2-MS exhibited inhibitory effects on HeLa cells and 10 μM 2-MS totally inhibited the cell growth. 2-MS inhibited the growth of all human tumor cell lines we examined with an IC50 between 2.5 to 12.5 μM (Figure. 7b). Many STAT3 and NF-κB pathway inhibitors inhibit cell growth by inducing apoptosis.(9–14,24,25) Therefore, we tested the ability of 2-MS to induce apoptosis. As shown in Figure. 7(c), 2-MS mostly induced necrosis of the tumor cells, as indicated by the single PI staining. We also examined the effects of 2-MS on the PARP cleavage in the tumor cells. However, we did not detect the PARP cleavage caused by 2-MS (data not shown).

Bottom Line: We have identified 2-methoxystypandrone (2-MS) from a traditional Chinese medicinal herb Polygonum cuspidatum as a novel dual inhibitor of JAK2 and IKK. 2-MS inhibits both interleukin-6-induced and constitutively-activated STAT3, as well as tumor necrosis factor-α-induced NF-κB activation. 2-MS specifically inhibits JAK and IKKβ kinase activities but has little effect on activities of other kinases tested.The inhibitory effects of 2-MS on STAT3 and NF-κB signaling can be eliminated by DTT or glutathione and can last for 4 h after a pulse treatment.We propose that the natural compound 2-MS, as a potent dual inhibitor of STAT3 and NF-κB pathways, is a promising anticancer drug candidate.

View Article: PubMed Central - PubMed

Affiliation: Division of Tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.

Show MeSH
Related in: MedlinePlus